EyeModelHub
Home Subspecialties Oculoplastics Model card
§Model Card

Blepharoptosis AI Platform (Xception CNN)

Automated screening for functionally significant blepharoptosis

Tan L. · 2025 · Singapore · doi:10.1080/01676830.2025.2497460
Open DOI
Classification CNN External photo Internally validated
More attributes
Anatomy · EyelidAnatomy · Periorbital soft tissueConditions · BlepharoptosisSingle-centern = NR patients · 771 eyes images
§01Overview

Brief overview

A GAN-augmented Xception convolutional neural network was developed to classify functionally significant blepharoptosis from cropped external periocular photographs. Using 771 eyes from a single tertiary oculoplastic center, the baseline model achieved sensitivity 0.68, specificity 0.89, and AUC 0.87, while augmentation with synthetic StyleGAN2-generated images improved sensitivity to 0.95 and AUC to 0.91 at the expense of specificity (0.67). Functional ptosis ground truth incorporated both MRD1 measurements and Humphrey visual field testing. The model was internally validated only, with no external testing, deployment, released code, or pretrained weights. The study is among the first in oculoplastics to explore GAN-generated synthetic periocular data augmentation for ptosis classification.

§02Performance
Headline performance

Baseline model: AUC 0.87; sensitivity 0.68; specificity 0.89; accuracy ~90%.

Baseline model: AUC 0.87
0.68
sensitivity
0.89
specificity
Full metrics — as reported
Baseline model: AUC 0.87; sensitivity 0.68; specificity 0.89; accuracy ~90%.
GAN-augmented model: AUC 0.91; sensitivity 0.95; specificity 0.67; accuracy ~90%.
Calibration · Uncertainty
Not reported.
Bias · Fairness
Not reported.
§03Data & Validation
Study designDiagnostic accuracy study
Center typeSingle-center
PatientsNot reported
Images / eyes771 eyes
Split~70/10/20
Reporting frameworks None stated
Age range>21
Sex (% female)Not reported
Race / ethnicity reportedN
Subgroup performanceN
§04Deployment
Deployment maturity
  1. Concept
  2. Prototype
  3. Internal val.
  4. External val.
  5. Regulator
  6. Clinical
Regulatory status
None No FDA / Health Canada / CE clearance.
Artifacts & license
Code repository none
Pretrained weights none
Live demo none
License Not specified
§05Quality Review · APPRAISE-AI
Total score
39 /100 Low
ClinicalDataMethodRobust.Report.Repro.
Sub-domain scores
Clinical relevance 4/4 100%
Data quality 14/24 58%
Methodological conduct 4/20 20%
Robustness of results 3/20 15%
Reporting quality 8/12 67%
Reproducibility 6/20 30%
Why this score?

The APPRAISE-AI tool grades AI/ML medical studies across 24 items in 6 subdomains, scored independently by two reviewers. The total reflects the methodological transparency of the publication — not the underlying clinical value of the model.

How to read this: high scores in clinical relevance and reporting with low scores in methodological conduct, robustness, or reproducibility is the dominant pattern in ophthalmic AI today.

Quality bands: Low <40 · Moderate 40–59 · High 60–79 · Very High 80+. Most published ophthalmic AI sits in the Low–Moderate band; studies that break into High typically combine multi-center datasets, prospective evaluation, and open-source release.

§06Full Metadata
Citation & identification
Bibliographic record
Model IDoculoplastics_tan_2025
Full author listLim, G., Leong, Y. Y., Elangovan, K., Ting, D., Chan, A. S., & Shen, S.
JournalOrbit
DOI10.1080/01676830.2025.2497460
ConditionsBlepharoptosis
Architecture
Model internals
Architecture familyCNN
Architecture detailXception-based convolutional neural network with and without GAN-generated synthetic images for data augmentation.
Funding & conflicts
Disclosures
FundingOphthalmology and Visual Sciences Academic Clinical Programme Grant, Singapore National Eye Centre, Singapore (05/FY2019/P1/09-A2)
Conflicts of interestNo conflicts
Card lifecycle
Status, version, reviewers
Card statusPublished
Card versionv1.0.0
First added2026-04-28
Last reviewed2026-04-28
Reviewersattribution opt-in pending
Update history
Card changelog
  • 2026-04-28 initial publication (v1.0.0)
← Back to Oculoplastics